Stock LHC LIFE HEALTHCARE GROUP HOLDINGS LIMITED
Add to a list
To use this feature you must be a member
Log inSign up

Financials Life Healthcare Group Holdings Limited

Equities

LHC

ZAE000145892

Healthcare Facilities & Services

End-of-day quote Johannesburg S.E.
Other stock markets
 06:00:00 2024-06-09 pm EDT 		5-day change 1st Jan Change
11.79 ZAR -1.75% Intraday chart for Life Healthcare Group Holdings Limited +1.64% -35.82%
Jun. 06 Lazard Asset Management LLC acquired an additional minority stake in Life Healthcare Group Holdings Limited. CI
May. 22 Transcript : Life Healthcare Group Holdings Limited, H1 2024 Earnings Call, May 22, 2024

Valuation

Fiscal Period: September 2019 2020 2021 2022 2023 2024 2025 2026
Capitalization 1 33,012 24,814 33,131 25,086 29,250 16,980 - -
Enterprise Value (EV) 1 44,330 38,930 43,509 35,969 29,250 21,484 21,381 21,224
P/E ratio 12.9 x -267 x 18.9 x 16.3 x 111 x 11.2 x 9.37 x 7.97 x
Yield 4.1% - 1.1% 2.32% 2.17% 4.34% 5.25% 6.06%
Capitalization / Revenue 1.29 x 0.98 x 1.23 x 0.89 x 1.29 x 0.7 x 0.66 x 0.62 x
EV / Revenue 1.73 x 1.53 x 1.62 x 1.28 x 1.29 x 0.89 x 0.83 x 0.77 x
EV / EBITDA 7.74 x 8.96 x 8.61 x 7.14 x 8.14 x 5.69 x 4.97 x 4.46 x
EV / FCF 17.1 x 18.7 x 13.4 x 19.1 x 9.29 x -1,074 x 13.2 x 10.2 x
FCF Yield 5.85% 5.34% 7.45% 5.24% 10.8% -0.09% 7.55% 9.82%
Price to Book 2.04 x 1.46 x 1.83 x 1.33 x 1.44 x 1.2 x 1.09 x 1.01 x
Nbr of stocks (in thousands) 1,455,567 1,454,493 1,453,736 1,454,244 1,443,731 1,440,182 - -
Reference price 2 22.68 17.06 22.79 17.25 20.26 11.79 11.79 11.79
Announcement Date 11/21/19 11/19/20 11/18/21 11/17/22 11/16/23 - - -
1ZAR in Million2ZAR
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: September 2019 2020 2021 2022 2023 2024 2025 2026
Net sales 1 25,672 25,386 26,885 28,206 22,641 24,177 25,849 27,419
EBITDA 1 5,727 4,346 5,051 5,039 3,594 3,777 4,298 4,756
EBIT 1 3,905 2,108 2,980 2,701 - 2,634 3,026 3,417
Operating Margin 15.21% 8.3% 11.08% 9.58% - 10.9% 11.71% 12.46%
Earnings before Tax (EBT) 1 3,706 581 2,409 2,482 1,911 2,402 2,653 3,087
Net income 1 2,569 -93 1,754 1,531 264 1,714 1,763 2,075
Net margin 10.01% -0.37% 6.52% 5.43% 1.17% 7.09% 6.82% 7.57%
EPS 2 1.758 -0.0640 1.206 1.058 0.1830 1.051 1.258 1.479
Free Cash Flow 1 2,595 2,077 3,243 1,884 3,147 -20 1,614 2,083
FCF margin 10.11% 8.18% 12.06% 6.68% 13.9% -0.08% 6.24% 7.6%
FCF Conversion (EBITDA) 45.31% 47.79% 64.21% 37.39% 87.56% - 37.55% 43.81%
FCF Conversion (Net income) 101.01% - 184.89% 123.06% 1,192.05% - 91.53% 100.38%
Dividend per Share 2 0.9300 - 0.2500 0.4000 0.4400 0.5122 0.6192 0.7148
Announcement Date 11/21/19 11/19/20 11/18/21 11/17/22 11/16/23 - - -
1ZAR in Million2ZAR
Estimates

Income Statement Evolution (Quarterly data)

Fiscal Period: September 2020 S1 2020 S2 2021 S1 2021 S2 2022 S1 2022 S2 2023 S1 2023 S2 2024 S1 2024 S2
Net sales 1 13,244 12,142 13,004 13,881 13,544 14,662 15,290 7,351 11,741 12,380
EBITDA 2,923 - 2,418 2,633 - - 2,690 - - -
EBIT 1,847 - - - - - - - - -
Operating Margin 13.95% - - - - - - - - -
Earnings before Tax (EBT) - - - - - - - - - -
Net income - - - - - - - - - -
Net margin - - - - - - - - - -
EPS 2 0.5350 -0.5990 - 0.6710 0.4120 0.6460 0.3790 -0.1960 2.410 0.5300
Dividend per Share - - - - - - - - - -
Announcement Date 5/11/20 11/19/20 5/27/21 11/18/21 5/26/22 11/17/22 5/24/23 11/16/23 5/22/24 -
1ZAR in Million2ZAR
Estimates

Balance Sheet Analysis

Fiscal Period: September 2019 2020 2021 2022 2023 2024 2025 2026
Net Debt 1 11,318 14,116 10,378 10,883 - 4,504 4,401 4,244
Net Cash position 1 - - - - - - - -
Leverage (Debt/EBITDA) 1.976 x 3.248 x 2.055 x 2.16 x - 1.192 x 1.024 x 0.8924 x
Free Cash Flow 1 2,595 2,077 3,243 1,884 3,147 -20 1,614 2,083
ROE (net income / shareholders' equity) 16.5% 5.34% 9.34% 8.32% 5.42% 9.83% 14.6% 15.7%
ROA (Net income/ Total Assets) 4.42% 2.21% 3.93% 3.69% 2.4% 4.55% 7.7% 8.5%
Assets 1 58,130 -4,203 44,645 41,513 10,982 37,654 22,901 24,424
Book Value Per Share 2 11.10 11.70 12.40 13.00 14.00 9.820 10.80 11.60
Cash Flow per Share 2 3.200 2.780 3.530 2.920 3.210 1.800 1.960 2.150
Capex 1 2,060 1,964 1,899 2,348 1,523 2,178 1,685 1,695
Capex / Sales 8.02% 7.74% 7.06% 8.32% 6.73% 9.01% 6.52% 6.18%
Announcement Date 11/21/19 11/19/20 11/18/21 11/17/22 11/16/23 - - -
1ZAR in Million2ZAR
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Year-on-year evolution of the Yield

Change in Enterprise Value/EBITDA

Ratings for Life Healthcare Group Holdings Limited

Trading Rating
Investor Rating
ESG Refinitiv
A
More Ratings

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
6
Last Close Price
11.79 ZAR
Average target price
16.22 ZAR
Spread / Average Target
+37.59%
Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Other Healthcare Facilities & Services

1st Jan change Capi.
LIFE HEALTHCARE GROUP HOLDINGS LIMITED Stock Life Healthcare Group Holdings Limited
-35.82% 907M
HCA HEALTHCARE, INC. Stock HCA Healthcare, Inc.
+26.08% 89.38B
CVS HEALTH CORPORATION Stock CVS Health Corporation
-23.66% 75.67B
DR. SULAIMAN AL HABIB MEDICAL SERVICES GROUP COMPANY Stock Dr. Sulaiman Al Habib Medical Services Group Company
+7.82% 28.83B
FRESENIUS SE & CO. KGAA Stock Fresenius SE & Co. KGaA
+5.88% 18.25B
LABCORP HOLDINGS INC. Stock Labcorp Holdings Inc.
-13.80% 16.51B
QUEST DIAGNOSTICS INCORPORATED Stock Quest Diagnostics Incorporated
+2.60% 15.72B
NATERA, INC. Stock Natera, Inc.
+78.26% 13.71B
TENET HEALTHCARE CORPORATION Stock Tenet Healthcare Corporation
+82.29% 13.46B
FRESENIUS MEDICAL CARE AG Stock Fresenius Medical Care AG
+4.58% 12.4B
Other Healthcare Facilities & Services
  1. Stock Market
  2. Equities
  3. LHC Stock
  4. Financials Life Healthcare Group Holdings Limited